(Q33185983)

23 July 2017

The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients (English)

1 reference

23 July 2017

1 reference

1 reference

2

Milan Brázdil

1 reference

23 July 2017

7

Ivan Rektor

1 reference

23 July 2017

Martin Bares

1

1 reference

23 July 2017

Petr Kanovský

3

1 reference

23 July 2017

Pavel Jurák

4

1 reference

23 July 2017

Pavel Daniel

5

1 reference

23 July 2017

Miloslav Kukleta

6

1 reference

23 July 2017

1 January 2003

1 reference

23 July 2017

6

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

23 July 2017

9

1 reference

23 July 2017

3

1 reference

23 July 2017

139-144

1 reference

Oculomotor Abnormalities in Parkinson's Disease

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

PET study of voluntary saccadic eye movements in humans: basal ganglia-thalamocortical system and cingulate cortex involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Ocular motor and manual tracking in Parkinson's disease and the effect of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Quantitative Analysis of Ocular Movements in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Abnormalities of smooth eye and head movement control in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Sublingual apomorphine and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Subcutaneous apomorphine in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Rectal apomorphine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Apomorphine in the diagnosis and treatment of parkinsonian tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

1 reference

7 January 2021

Eye-Tracking Patterns in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Smooth pursuit dysfunction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Eye movements in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Smooth pursuit eye movement abnormality in severe major depression: effects of ECT and clinical recovery.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Smooth pursuit in senescence. Effects of target acceleration and velocity.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

The current model of basal ganglia organization under scrutiny

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Subcortical input to the smooth and saccadic eye movement subregions of the frontal eye field in Cebus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Changes in movement-related cortical potentials in Parkinson's patients before and after treatment with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900015-9

7 January 2021

10.1016/S1353-8020(02)00015-9

Identifiers

DOI

1 reference

23 July 2017

1 reference